Task: Answer the multiple choice question.
Question: Which drug exhibits a 11.196% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) NNC(=O)c1cncn1-c1ccc(F)cc1
(b) Cc1ccc(C2NC(=O)c3c(sc(C)c3C)N2)c(O)c1
(c) Cc1csc(NC(=O)CSC2=NS(=O)(=O)c3cc(F)ccc3N2)n1
Answer: c. Cc1csc(NC(=O)CSC2=NS(=O)(=O)c3cc(F)ccc3N2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1csc(NC(=O)CSC2=NS(=O)(=O)c3cc(F)ccc3N2)n1
Cc1csc(NC(=O)CSC2=NS(=O)(=O)c3cc(F)ccc3N2)n1
2-[(7-fluoro-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-3-yl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)acetamide